Aboubakr Mohamed Salama

8PUBLICATIONS
8CO-AUTHORS
Medical biotechnology not elsewhere classifiedElectrical energy generation (incl. renewables, excl. photovoltaics)Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 19, 2026
The Red Flags Were Missing, the Indication Was Not: Genetic Testing in Heart Failure and Cardiomyopathy.

|Sep 18, 2026
Reintroducing FABP5 in adulthood activates cell cycle in cardiomyocytes.

|May 08, 2026
Nitric oxide supplementation during extracorporeal resuscitation drives oxidative-inflammatory signaling and metabolic suppression in the post-cardiac arrest heart.

|Jan 11, 2025
Pharmacological or genetic inhibition of LTCC promotes cardiomyocyte proliferation through inhibition of calcineurin activity.

Lynn A C Devilée, Abou Bakr M Salama, Jessica M Miller

|Dec 11, 2023
Pharmacological or genetic inhibition of LTCC promotes cardiomyocyte proliferation through inhibition of calcineurin activity.

Lynn A C Devilée, Jessica M Miller, Janice D Reid

|Jul 24, 2021
Induced Cardiomyocyte Proliferation: A Promising Approach to Cure Heart Failure.

Abou Bakr M Salama, Ahmad Gebreil, Tamer M A Mohamed

Pageof 2

Frequent Collaborators

3 joint publications

Riham R E Abouleisa

2 joint publications

Lynn A C Devilée

2 joint publications

James E Hudson

1 joint publications

Yibing Nong